NASDAQ:RVNC - Revance Therapeutics Price Target & Analyst Ratings

$12.60
-0.27 (-2.10 %)
(As of 07/21/2019 09:42 AM ET)
Today's Range
$12.58
Now: $12.60
$13.05
50-Day Range
$10.66
MA: $11.85
$12.97
52-Week Range
$10.37
Now: $12.60
$30.60
Volume296,838 shs
Average Volume468,868 shs
Market Capitalization$554.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.02

Analyst Ratings

Revance Therapeutics (NASDAQ:RVNC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for Revance Therapeutics in the last 12 months. Their average twelve-month price target is $34.7288, suggesting that the stock has a possible upside of 175.63%. The high price target for RVNC is $50.00 and the low price target for RVNC is $17.83. There are currently 2 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.802.782.88
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $34.7288$34.7288$35.4717$48.1667
Price Target Upside: 175.63% upside225.48% upside112.53% upside179.55% upside

Revance Therapeutics (NASDAQ:RVNC) Consensus Price Target History

Revance Therapeutics (NASDAQ:RVNC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/11/2019BarclaysInitiated CoverageOverweight ➝ Overweight$28.00MediumView Rating Details
4/24/2019MizuhoReiterated RatingBuy$37.00MediumView Rating Details
3/1/2019SunTrust BanksLower Price TargetPositive ➝ Buy$29.00HighView Rating Details
2/15/2019Wells Fargo & CoInitiated CoverageMarket Perform$17.83LowView Rating Details
2/14/2019HC WainwrightInitiated CoverageBuy$25.00LowView Rating Details
1/28/2019Stifel NicolausInitiated CoverageBuy$50.00HighView Rating Details
11/16/2018GuggenheimUpgradeNeutral ➝ Buy$41.00LowView Rating Details
11/1/2018Cantor FitzgeraldReiterated RatingBuy$50.00HighView Rating Details
9/17/2018Piper Jaffray CompaniesReiterated RatingBuyLowView Rating Details
9/17/2018JMP SecuritiesDowngradeOutperform ➝ Market PerformHighView Rating Details
3/26/2018Needham & Company LLCInitiated CoverageBuy$42.00LowView Rating Details
3/5/2018Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$60.00MediumView Rating Details
3/1/2018William BlairReiterated RatingOutperformMediumView Rating Details
1/17/2018CowenSet Price TargetBuy$55.00LowView Rating Details
(Data available from 7/21/2017 forward)
This page was last updated on 7/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel